Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2005
11/10/2005US20050250770 Fused heterocyclic compounds
11/10/2005US20050250761 such as -Piperidin-1-yl-but-2-enoic acid [4(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yl]-amide, used as tyrosine kinase inhibitors, for the prevention of proliferative diseases, including cancer, atherosclerosis, restenosis, endometriosis and psoriasis
11/10/2005US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules
11/10/2005DE4303335B4 Ferroelektrische Flüssigkristall-Mischungen mit kurzer ferroelektrischer Ganghöhe A ferroelectric liquid crystal mixtures with a short pitch ferroelectric
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564589A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564587A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564288A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidin-2-yl and 5, 6, 7, 8-tetrahydro-quinazolin-2-yl compounds
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2564175A1 Chemical compounds
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005CA2562416A1 Electroluminescent device
11/09/2005EP1592697A1 Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells
11/09/2005EP1592695A1 Pyrimidines, methods for the production thereof, and use thereof
11/09/2005EP1592672A2 Process for preparation of 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol
11/09/2005EP1592425A2 New arylpiperazinyl compounds
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1165576B1 Process for preparing amine platinum complexes
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005EP1100788B1 Substituted quinazoline derivatives
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1066266B1 Cyclin dependent kinase inhibitors
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694872A Tetrahydropyrimidine-2-one derivatives and their uses
11/09/2005CN1694871A Imidazolopyridines and methods of making and using the same
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1694708A Inhibitors of tgfbeta
11/09/2005CN1694698A Pyrazolopyridines and methods of making and using the same
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962922 Alkynylated quinazoline compounds
11/08/2005US6962920 6-aminofuro(2,3-d)pyrimidines and 6-aminopyrrolo(2,3-d) pyrimidines useful in treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/08/2005CA2297294C Phosphonomethoxymethylpurine/pyrimidine derivatives
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103022A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
11/03/2005WO2005103014A1 2,4-dioxo-5-(2-hydroxy-3,5-dichloro-benzylidene)imino-1,3-pyrimidine salts
11/03/2005WO2005103013A1 Therapeutic agent for nonviral hepatitis
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102980A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
11/03/2005WO2005003103A3 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
11/03/2005US20050245555 Tri-substituted ureas as cytokine inhibitors
11/03/2005US20050245554 Substituted pyrimidines
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245530 Monocyclic heterocycles as kinase inhibitors
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245499 Heterocyclic protein kinase inhibitors and uses thereof
11/03/2005DE4000535B4 1,4-Disubstituierte 2,6-Difluorbenzolverbindungen und flüssigkristallines Medium 1,4-Disubstituted 2,6-Difluorbenzolverbindungen and liquid crystalline medium
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/02/2005EP0907642B1 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
11/02/2005CN1692108A Pesticidal heterocycles
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100357A1 Mitotic kinesin inhibitors
10/27/2005WO2005100333A1 Methods and intermediates for the synthesis of delta-9 tetrahydrocannabinol
10/27/2005WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents
10/27/2005WO2005099688A2 Cyclic compounds
10/27/2005WO2004089366A8 Bicyclic compounds as nr2b receptor antagonists
10/27/2005WO2004058704A8 Quinazolinones as potassium channel modulators
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239811 Tri-substituted ureas as cytokine inhibitors
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239797 Isoquinoline and quinazoline derivatives having a combined 5HT1A, 5HT1B, and 5HT1D receptor activity
10/27/2005US20050239794 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
10/27/2005US20050239793 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239655 3-heterocyclyl substituted benzoic acid derivatives
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005CA2562244A1 Cyclic compounds
10/27/2005CA2561904A1 Mitotic kinesin inhibitors
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587803A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
10/26/2005EP1587516A1 Amide and ester matrix metalloproteinase inhibitors
10/26/2005EP1587474A2 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1131312B1 Novel pyrimidine derivatives and processes for the preparation thereof
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005CN1688552A Pyrimidine derivatives and their use as CB2 modulators
10/26/2005CN1688551A Process for preparing the calcium salt of rosuvastatin
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1687037A Compound of 1-pyrimidine ketone group-4-chlorine-5-benzoic ethers and preparation method thereof
10/26/2005CN1687036A Method for preparing 4, 6 dichloropyridine
10/26/2005CN1224617C Preparation of 4, 6-dihydric pyrimidine
10/25/2005US6958399 Compounds capable of activating cholinergic receptors
10/25/2005US6958345 syn-N1-(2-hydroxymethylcyclopropylidenemethyl)-cytosine for example; treating HIV, herpes viruses, Epstein-Barr virus (EBV), hepatitis B virus
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005US6958332 Treating an interleukin-12 overproduction-related disorder; treating rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 427